IDH1 and central nervous system cancer: IDH1 mutations, producing the oncometabolite 2-HG that disrupts cell differentiation and influences tumor behavior, are commonly found in lower-grade gliomas and certain glioblastomas [50], reflecting their distinct metabolic profile.